{"id":"https://openalex.org/W2139381148","doi":"https://doi.org/10.1158/0008-5472.can-11-4069","title":"Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity","display_name":"Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity","publication_year":2012,"publication_date":"2012-02-07","ids":{"openalex":"https://openalex.org/W2139381148","doi":"https://doi.org/10.1158/0008-5472.can-11-4069","mag":"2139381148","pmid":"https://pubmed.ncbi.nlm.nih.gov/22311673"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-11-4069","doi":"https://doi.org/10.1158/0008-5472.can-11-4069","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-11-4069","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/72/7/1614/2678919/1614.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/72/7/1614/2678919/1614.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113590696","display_name":"Suzanne E. Little","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Suzanne E. Little","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101512344","display_name":"Sergey Popov","orcid":"https://orcid.org/0000-0003-1172-3557","observed_orcids":["https://orcid.org/0000-0003-1172-3557"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sergey Popov","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018676630","display_name":"Alexa Jury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alexa Jury","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018808600","display_name":"Dorine A. Bax","orcid":"https://orcid.org/0009-0007-7327-2073","observed_orcids":["https://orcid.org/0009-0007-7327-2073"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dorine A. Bax","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029861545","display_name":"Lawrence J. Doey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lawrence Doey","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom","Clinical Neuropathology, King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Clinical Neuropathology, King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011302176","display_name":"Safa Al\u2010Sarraj","orcid":"https://orcid.org/0000-0002-6783-3571","observed_orcids":["https://orcid.org/0000-0002-6783-3571"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Safa Al-Sarraj","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom","Clinical Neuropathology, King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Clinical Neuropathology, King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087689900","display_name":"Juliane Margarete J\u00fcrgensmeier","orcid":"https://orcid.org/0000-0001-8438-2429","observed_orcids":["https://orcid.org/0000-0001-8438-2429"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Juliane M. Jurgensmeier","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom","Clinical Neuropathology, King's College Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Clinical Neuropathology, King's College Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031621086","display_name":"Chris Jones","orcid":"https://orcid.org/0000-0001-8118-2296","observed_orcids":["https://orcid.org/0000-0001-8118-2296"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Chris Jones","raw_affiliation_strings":["Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","AstraZeneca, Alderley Park, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Divisions of 1Molecular Pathology and 2Cancer Therapeutics, The Institute of Cancer Research, Sutton, United Kingdom; 3Clinical Neuropathology, King's College Hospital, London, United Kingdom; and 4AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031621086"],"corresponding_institution_ids":["https://openalex.org/I105036370","https://openalex.org/I142947616","https://openalex.org/I4210153400"],"apc_list":null,"apc_paid":null,"fwci":6.2099,"has_fulltext":true,"cited_by_count":123,"citation_normalized_percentile":{"value":0.97610126,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"72","issue":"7","first_page":"1614","last_page":"1620"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9139999747276306},{"id":"https://openalex.org/keywords/gene-amplification","display_name":"gene amplification","score":0.9800000190734863},{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.8659999966621399},{"id":"https://openalex.org/keywords/mutual-exclusivity","display_name":"mutual exclusivity","score":0.8579999804496765},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pdgfra","display_name":"PDGFRA","score":1.0},{"id":"https://openalex.org/keywords/multicolor-fish","display_name":"multicolor FISH","score":0.7839999794960022},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/tumor-genomic-profiling","display_name":"tumor genomic profiling","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.6393203139305115},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.6324177980422974},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.6201980113983154},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.598074734210968},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.591776430606842},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5789392590522766},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5382748246192932},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5348687767982483},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.5323681235313416},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.36902856826782227},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24808135628700256},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.24777036905288696},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.0},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005784","descriptor_name":"Gene Amplification","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018628","descriptor_name":"Gene Dosage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020796","descriptor_name":"Receptor, Platelet-Derived Growth Factor alpha","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.can-11-4069","doi":"https://doi.org/10.1158/0008-5472.can-11-4069","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-11-4069","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/72/7/1614/2678919/1614.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:22311673","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22311673","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/33ae543e-dd10-477d-9b36-72ea04c1467a","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/33ae543e-dd10-477d-9b36-72ea04c1467a","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Little, S E, Popov, S, Jury, A, Bax, D A, Doey, L, Al-Sarraj, S, Jurgensmeier, J M & Jones, C 2012, 'Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity', Cancer Research, vol. 72, no. 7, pp. 1614-1620. https://doi.org/10.1158/0008-5472.CAN-11-4069","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-11-4069","doi":"https://doi.org/10.1158/0008-5472.can-11-4069","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-11-4069","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/72/7/1614/2678919/1614.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139381148.pdf","grobid_xml":"https://content.openalex.org/works/W2139381148.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W81665236","https://openalex.org/W1560814177","https://openalex.org/W1967304777","https://openalex.org/W1989891384","https://openalex.org/W1999356404","https://openalex.org/W2020063072","https://openalex.org/W2025183726","https://openalex.org/W2032518018","https://openalex.org/W2035151737","https://openalex.org/W2040827479","https://openalex.org/W2048982865","https://openalex.org/W2067256262","https://openalex.org/W2094269006","https://openalex.org/W2113942802","https://openalex.org/W2131981377","https://openalex.org/W2145755261","https://openalex.org/W2153554640","https://openalex.org/W2159656414","https://openalex.org/W2161253116","https://openalex.org/W2161289668"],"related_works":["https://openalex.org/W1996765032","https://openalex.org/W2061760261","https://openalex.org/W1989891384","https://openalex.org/W4386084076","https://openalex.org/W2006955669","https://openalex.org/W1981145466","https://openalex.org/W2017388864","https://openalex.org/W2018101957","https://openalex.org/W2170138671","https://openalex.org/W2562504299"],"abstract_inverted_index":{"Intratumoral":[0],"heterogeneity":[1],"in":[2,26,95,105,129,142],"human":[3],"solid":[4],"tumors":[5,110],"represents":[6],"a":[7,74,89,99],"major":[8],"barrier":[9],"for":[10,154],"the":[11,23,31,46,62,106,114,133,138,146,165,177],"development":[12],"of":[13,33,49,67,88,102,108,145],"effective":[14],"molecular":[15,24,180],"treatment":[16,19],"strategies,":[17],"as":[18,159],"efficacies":[20],"will":[21],"reflect":[22],"variegation":[25],"individual":[27],"tumors.":[28],"In":[29,84,112],"glioblastoma,":[30],"generation":[32],"composite":[34],"genomic":[35,47],"profiles":[36],"from":[37,79],"bulk":[38],"tumor":[39,63,76],"samples":[40],"has":[41],"allowed":[42],"one":[43,136],"to":[44,54,126,173,179],"map":[45],"amplifications":[48],"putative":[50],"genetic":[51],"drivers":[52],"and":[53,122],"prioritize":[55],"therapeutic":[56,157],"targeting":[57],"strategies":[58],"aimed":[59],"at":[60],"eradicating":[61],"burden.":[64],"Notably,":[65],"amplification":[66,104,170],"multiple":[68],"receptor":[69],"tyrosine":[70],"kinases":[71],"(RTK)":[72],"within":[73],"single":[75],"specimen":[77],"obtained":[78],"patients":[80],"is":[81],"frequently":[82],"observed.":[83],"this":[85],"study,":[86],"use":[87],"detailed":[90],"multicolor":[91],"FISH":[92],"mapping":[93],"procedure":[94],"pathologic":[96],"specimens":[97],"revealed":[98],"mutual":[100],"exclusivity":[101],"gene":[103,140,169],"majority":[107],"glioblastoma":[109],"examined.":[111],"particular,":[113],"two":[115],"most":[116],"commonly":[117],"amplified":[118],"RTK":[119],"genes,":[120],"EGFR":[121],"PDGFRA,":[123],"were":[124],"found":[125],"be":[127],"present":[128],"variable":[130],"proportions":[131],"across":[132],"tumors,":[134],"with":[135,167],"or":[137,176],"other":[139],"predominating":[141],"certain":[143],"areas":[144],"same":[147],"specimen.":[148],"Our":[149],"findings":[150],"have":[151],"profound":[152],"implications":[153],"designing":[155],"efficacious":[156],"regimens,":[158],"it":[160],"remains":[161],"unclear":[162],"that":[163],"how":[164],"cells":[166],"different":[168],"events":[171],"contribute":[172],"disease":[174],"propagation":[175],"response":[178],"targeted":[181],"therapies.":[182]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}